Cadrenal Therapeutics Inc...

16.92
-0.75 (-4.24%)
At close: Apr 03, 2025, 3:59 PM
17.43
3.01%
After-hours: Apr 03, 2025, 07:45 PM EDT

Cadrenal Therapeutics Common Stock Revenue

Cadrenal Therapeutics Common Stock reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2024, Cadrenal Therapeutics Common Stock generated $0 in revenue.
Revenue (ttm)
$0
Revenue Growth
0%
Price / Sales Ratio
0
Revenue / Employee
$0
Employees
4
Market Cap
31.8M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 0 n/a
Dec 31, 2023 0 n/a
Dec 31, 2022 0 n/a